NEW YORK, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have
commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead
plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links
provided. There is no cost or obligation to you.
Glencore plc (OTCMKTS: GLCNF GLNCY)
Class Period: September 30, 2016 - July 2, 2018
Lead Plaintiff Deadline: September 7, 2018
Join the action: http://www.zlk.com/pslra-d/glencore?wire=3
About the lawsuit: Throughout the class period, Glencore plc allegedly made materially false and/or misleading statements and/or
failed to disclose that: (i) Glencore’s conduct would subject it to heightened scrutiny by U.S. and foreign government bodies
resulting in investigations into the company’s compliance with money laundering and bribery laws, as well as the Foreign Corrupt
Practices Act; and (ii) as a result, defendants’ statements about Glencore’s business, operations, and prospects were materially
false and/or misleading and/or lacked a reasonable basis at all relevant times.
On May 18, 2018, Bloomberg reported that the U.K.'s Serious Fraud Office was preparing to open a formal bribery investigation
into Glencore. Then on July 3, 2018, Glencore disclosed that the U.S. Department of Justice issued its subsidiary a subpoena to
produce documents and other records in connection with its compliance with U.S. money laundering statutes and the Foreign Corrupt
Practices Act.
To learn more about the Glencore plc class action contact jlevi@levikorsinsky.com.
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD)
Class Period: April 29, 2016 - July 9, 2018
Lead Plaintiff Deadline: September 17, 2018
Join the action: http://www.zlk.com/pslra-d/acadia?wire=3
About the lawsuit: During the class period, ACADIA Pharmaceuticals Inc. allegedly made materially false and/or misleading
statements and/or failed to disclose that: (1) adverse events and safety concerns related to NUPLAZID threatened the drug’s initial
and continuing FDA approval; (2) ACADIA engaged in business practices likely to attract regulatory scrutiny; and (3) as a result,
defendants’ statements about ACADIA’s business, operations, and prospects, were materially false and/or misleading and/or lacked a
reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To learn more about the ACADIA Pharmaceuticals Inc. class action contact jlevi@levikorsinsky.com.
Farmland Partners Inc. (NYSE: FPI)
Class Period: March 16, 2016 - July 10, 2018
Lead Plaintiff Deadline: September 10, 2018
Join the action: http://www.zlk.com/pslra-d/farmland-partners-inc?wire=3
About the lawsuit: Farmland Partners Inc. allegedly made materially false and/or misleading statements during the class period
and/or failed to disclose that: (1) Farmland artificially increased revenues by making loans to related-party tenants who
round-tripped the cash back to Farmland as rent; (2) as a result, Farmland’s earnings during fiscal year 2017 were materially
overstated; (3) the true extent and effect of Farmland’s non-arm’s length transactions; and (4) as a result, Defendants’ statements
about the Company’s business, operations and prospects were materially false and misleading and/or lacked reasonable bases at all
relevant times.
To learn more about the Farmland Partners Inc. class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys
have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of
dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
